UMC Utrecht, Department of Radiation Oncology, Utrecht, The Netherlands
Purpose or Objective: To present long-term results on disease control and late toxicity in both primary and postoperative re-irradiation in the head and neck region.
Material and Methods:
Retrospective single center analysis of 137 patients re-irradiated between 1986 and 2013 for a recurrent or second primary malignancy. Inclusion criteria were a prescribed dose of at least 45 Gy in first treatment and re-treatment and histological proof of disease. Exclusion criteria were age under 18 years, the presence of metastatic disease and the use of brachytherapy. Endpoints were locoregional control (LRC), disease-free survival (DFS), eventfree survival (EFS), overall survival (OS) and grade ≥3 late complications according to EORTC/RTOG criteria. EFS includes both disease recurrence and late treatment complication as an event. As 3D-dose distribution data was not available for all patients, a descriptive approach was used to determine the highest cumulative dose in radiation overlap and organs at risk (spinal cord, larynx, mandible and optical nerve).
Results: Patient and tumor characteristics are presented in table 1.
The median re-irradiation and cumulative radiation dose were 60 Gy (range 45-70) and 126 Gy (range 68-138) respectively. Two-and five-year LRC were 52% and 40%, twoand five-year DFS were 38% and 28% respectively (figure 1). There were 17 observations of serious late toxicity in 11 patients (actuarial 26% at 5 years): chondronecrosis (n= 1), osteoradionecrosis (n= 8), soft tissue necrosis (n= 3), arterial blowout (n= 3), and stricture/fistula (n= 2). Three cases of treatment-related death were reported. Multivariate analysis revealed IMRT as re-irradiation technique to be protective of late complications (HR, 0.10; 95% CI, 0.01-0.96). The fiveyear actuarial EFS was 18%.
One-hundred-and-seven patients (78%) were re-irradiated post-operatively and had a better LRC in comparison to reirradiation alone (actuarial 5-yr 46% vs 16%, p<0.05). Of patients re-irradiated alone without surgery, patients reirradiated for a second primary tumor had significant better LRC-rates in comparison with patients re-irradiated for recurring tumors (actuarial 5-yr 44% vs 0% p<0.05). Four cases of mandibular osteoradionecrosis were seen (cumulative dose range 106-128 Gy). Fifty-three patients received a cumulative dose of 100 Gy or higher. The actuarial 5-year mandibular necrosis rate in this group was 26%.
Conclusion:
Re-irradiation in the head and neck region for a recurrent or second primary malignancy is associated with LRC-rates of 40%. Results in patients re-irradiated postoperatively are more favorable. Approximately one in six patients survived at 5 years without a recurrence or a serious late toxicity. The most important limitation for re-irradiation is late toxicity, which can be limited with current IMRT techniques. patients, increasing the median follow-up from 22 to 38 months after RT. The endpoint, HT, was defined as TSH>4.0 mU/l. Data were analyzed using a mixture model taking both thyroid volume (Vthyroid) and dose (Dmean) into account. From the repeated blood samples, latency was estimated and both the latency time function and NTCP models in AUH were compared to OUH. Validation was performed using a calibration plot of binned groups of patients showing the clinically observed outcome in the validation cohort compared with the predicted outcome from the original NTCP model.
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Results:
With the additional follow-up, 40 patients (20%) developed HT (19 after one TSH assessment). Dmean and Vthyroid were still significant risk factors for HT, OR= 1.11 (1.06-1.19) and OR = 0.85 (0.74-0.93), respectively. The cumulative events showed that 94% (59-100%) of the events would develop within the first five years after RT in the validation cohort, in line with the original cohort's 97% (85-100%). Mean thyroid volumes were 17.4 (OUH) and 17.3 (AUH) cm3, and tolerance estimates around this level showed TD25 = 38 Gy and 34 Gy, respectively, at 15 cm3 and 48 Gy and 42Gy, respectively, at 20 cm3. The calibration plot (Fig. 1) showed good agreement between the observed incidences of HT in the validation group versus the expected probability of HT from the original model. Thus, the NTCP model has external validity in the cohort with multiple blood tests.
Conclusion:
Increasing thyroid dose and a decreasing thyroid volume were confirmed as significant risk factors for radiation-induced HT, which likely develops within the first five years after RT. The calibration plot shows that the original NTCP model has external validity, supporting that risk estimates from the NTCP model may be used to support clinical treatment planning decisions relating to development of hypothyroidism after RT to the neck area. Purpose or Objective: Head and neck cancer (HNC) is the sixth most common type of cancer in Europe. Its early symptoms are usually non-specific and easy to miss, which in many patients lead to late presentation and diagnosis. Main risk factors of HNC include alcohol consumption and smoking. Both of them are usually present in young people, thus health education in this group is of great importance. The aim of the study was to assess the level of HNC awareness among young population in Poland.
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Material and Methods:
An anonymous online survey about HNC was conducted among 1903 people in the age of 18-35 years, mainly students of high schools and universities. The closed-ended questions concerned HNC risk factors, symptoms and prognosis. Participation in the study was voluntary.
Results: 85% of respondents had heard about HNC. The main source of information was the Internet (57%). Seventy-eight percent of participants associated smoking with HNC development, but alcohol consumption was mentioned by less than a half, and human papillomavirus (HPV) infection by approximately ⅓ of them. The main risk factors mentioned by students of non-medical schools included smoking (66%), stress (33%), and excessive sunbathing (32%). One fourth of the respondents (38% when excluding medical students) were unaware of any HNC early symptoms. The symptoms mentioned most often included chronic hoarseness (55%), lump in the neck (52%), and chronic sore throat (51%). Over ¾ of medical students and half of other respondents were aware that early diagnosis is associated with a great chance
